Cargando…
Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates
Inhibitors of the cyclo-oxygenase component of prostaglandin-H(2) synthetase, namely indomethacin and ibuprofen, are commonly used in the treatment of hemodynamically significant patent ductus arteriosus. These drugs are associated with serious adverse events, including gastrointestinal perforation,...
Autores principales: | Terrin, Gianluca, Conte, Francesca, Scipione, Antonella, Bacchio, Erica, Conti, Maria Giulia, Ferro, Rosalia, Ventriglia, Flavia, De Curtis, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940001/ https://www.ncbi.nlm.nih.gov/pubmed/24555510 http://dx.doi.org/10.1186/1824-7288-40-21 |
Ejemplares similares
-
Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?
por: Bardanzellu, Flaminia, et al.
Publicado: (2017) -
Morbidity associated with patent ductus arteriosus in preterm newborns: a retrospective case-control study
por: Terrin, Gianluca, et al.
Publicado: (2021) -
Echocardiography-Guided Management of Preterms With Patent Ductus Arteriosus Influences the Outcome: A Cohort Study
por: Terrin, Gianluca, et al.
Publicado: (2020) -
New architectural design of delivery room reduces morbidity in preterm neonates: a prospective cohort study
por: Terrin, Gianluca, et al.
Publicado: (2016) -
Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus
por: Engbers, Aline G.J., et al.
Publicado: (2020)